Additional information | |
|---|---|
| Department | IMMUNOLOGY |
| Speciality Name | PAPP-A |
| Test type | Pathology |
| Also known as | Pregnancy associated plasma protein-A |
| Report | 3-4 Days |
| Availability | All centre |
No Patient preparation needed.
The PAPP-A Test is an important component of first trimester prenatal screening. Pregnancy Associated Plasma Protein-A is produced by the placenta and normally increases as pregnancy progresses. Measuring its concentration provides valuable information about placental function and fetal development. Low PAPP-A levels may be associated with an increased risk of chromosomal abnormalities, pregnancy complications, restricted fetal growth, pre-eclampsia, preterm birth and stillbirth. The PAPP-A Test is performed alongside maternal age ultrasound findings and other blood test results to calculate an overall risk estimate. Because it is a simple blood test and carries no risk to developing babies, it has become a routine part of prenatal care in many healthcare settings. Early identification of pregnancies at increased risk allows healthcare professionals to offer additional investigations, closer monitoring and appropriate medical management throughout pregnancy.
The PAPP-A (Pregnancy-Associated Plasma Protein-A) Test is a laboratory blood test used to measure the level of Pregnancy Associated Plasma Protein-A in a mother's blood. PAPP-A is a protein produced mainly by the placenta during pregnancy and plays an important role in growth and the development of the fetus. The test is most performed during the first trimester of pregnancy between the 11 and 13 weeks plus 6 days as part of the prenatal screening for chromosomal abnormalities. The PAPP-A Test is combined with free Beta hCG blood test and nuchal translucency NT ultrasound to assess the risk of conditions such as Down syndrome Trisomy 21 Edwards syndrome Trisomy 18 and Patau syndrome Trisomy 13. It is a screening test rather than a diagnostic test meaning that it estimates the likelihood of these conditions but does not confirm their presence.
| S. No | Cause | Description |
| 1 | The First Trimester Pregnancy | Routine prenatal screening between 11 and 13 weeks |
| 2 | Screening for Patau Syndrome | Evaluation of Trisomy 13 risk |
| 3 | Advanced Maternal Age | Assessment of pregnancies with increased genetic risk |
| 4 | Family History of Genetic Disorders | Prenatal risk evaluation |
| 5 | Abnormal Ultrasound Findings | Further assessment of fetal health |
| S. No | Condition | Description |
| 1 | The Down Syndrome Trisomy 21 | The Chromosomal disorder causing developmental and intellectual disability |
| 2 | The Edwards Syndrome Trisomy 18 | The Severe chromosomal abnormality affecting fetal development |
| 3 | The Patau Syndrome Trisomy 13 | The Rare genetic disorder associated with multiple congenital abnormalities |
| 4 | The Fetal Growth Restriction FGR | The Poor growth of the fetus during pregnancy |
| 5 | The Intrauterine Growth Restriction IUGR | The Reduced fetal growth due to placental insufficiency |
In Delhi there are many diagnostic centres to book the online tests for PAPP-A but patients prefer City Imaging for the best results and at a very affordable price.
PAPP-A near me in Delhi is the City Imaging. This centre provides the best results and the rates of the tests are very affordable as compared to others.
Patients can book the test PAPP-A online at City Imaging by visiting the website and book the test appointment online. There are also the customer care numbers on the website that the patient can dial and book our test. In Delhi there are many diagnostic centres to book the online tests for PAPP-A but patients prefer City Imaging for the best results and at a very affordable price.
PAPP-A price in Delhi may range from INR 900 to INR 1800. The price may vary depending on various factors like location of diagnostic centres. It is expensive because of the advanced equipment and the skilled professionals used for this test.
In Delhi patients choose City Imaging for the PAPP-A test because this centre has the best machines that give the best results. The diagnostic centre has very good patient service with the helpline numbers for round the clock availability.
The PAPP-A Test is an important prenatal screening investigation that helps to assess the health of pregnancy and estimate the risk of certain chromosomal abnormalities during the first trimester. By measuring the Pregnancy Associated Plasma Protein-A levels in mother's blood the test provides valuable information about the placental function and fetal development. When combined with ultrasound findings, maternal age and other biochemical markers the PAPP-A Test improves the accuracy of prenatal risk assessment and helps to identify pregnancies that may benefit from the additional investigations or closer medical monitoring. In final words the PAPP-A Test is a safe, reliable and valuable component of first trimester prenatal care contributing significantly to early detection and management of high risk pregnancies.
It is a blood test that is performed during early pregnancy to measure Pregnancy Associated Plasma Protein-A levels.
It is performed between 11 weeks and 13 weeks plus 6 days of the pregnancy.
It helps to screen for chromosomal abnormalities and assess placental function.
No it is a screening test that estimates the risk rather than confirms diagnosis.
No, fasting is not required.
Related tests